Prior studies from this laboratory have indicated that previously unstimulated lymph node cells may be altered to a state resembling transplantation immunity by incubation in vitro with ribonucleic acid (RNA) extracted from specifically sensitized lymph nodes (2, 3) . The assay of transplantation immunity used in these experiments was the transfer reaction of Brent, Brown, and Medawar (4), which is a delayed inflammatory reaction in the skin produced by the intradermal injection of immune cells into the animal against which the anticipated immune response is directed. Our finding that lymphoid RNA from an immunized animal may confer upon otherwise unsensitized lymph node cells the capacity to produce a transfer reaction has been confirmed by Clarke and Wilson (5) and more recently by others (6, 7) .
However, the transfer reaction may be criticized as a test for transplantation immunity. It is possible by gross inspection to confuse the transfer reaction with other less specific inflammatory responses in the skin. Moreover, while reports from Brent, Brown, and Medawar (4), from Dvorak and Waksman (8) , and from this laboratory (2, 3, 9) have demonstrated adequately the association between the production of a transfer reaction and the state of transplantation immunity, there is no conclusive evidence that the capacity to produce a transfer reaction is equivalent to the capacity to manifest transplantation immunity in * Submitted for publication April 30, 1964 ; accepted July 16, 1964. This work was supported in part by U. S. Public Health Service research grants AM-07495 and CA-05725 and by American Cancer Society grant T 166-B.
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t Markle Scholar in Medical Sciences. Present address: Massachusetts Memorial Hospitals, Boston, Mass. a more conventional manner, for example, by the rejection of tissue homografts. Therefore our present study was undertaken to determine whether or not heightened immunity to skin homografts could be transferred from one animal to another by RNA extracted from sensitized lymph nodes.
Methods
Outbred adult rabbits of three breeds, New Zealand white, California white, and Dutch, were used as experimental animals. The rabbits weighed from 1.5 to 3.5 kg. They were caged individually in an air-conditioned animal room and maintained on a diet of Purina rabbit chow and water. The techniques of, full thickness skin grafting, excision of lymph nodes and spleen, and preparation of lymphoid cell suspensions used in this laboratory have been described previously (3, 9) . In the present experiments spleen and lymph node cell suspensions were prepared in Trowell's medium' rather than the Eagle Hela medium used in previous studies.
The extraction of RNA from lymph node tissue by the cold phenol method has also been described (3, 9) . In the present experiments the RNA extraction procedure was altered in the one respect that the lymph node homogenate was treated with sodium lauryl sulfate (added in a quantity sufficient to make a 0.1% concentration) at room temperature for 5 minutes before beginning the phenol extractions. The RNA preparation, 5 to 15 ml in volume, was always used immediately after extraction and was made 0.7 M with respect to sucrose and adjusted to pH 7.0 to 7.4 before incubation with lymphoid cells. The concentration of RNA was determined by the optical density at 260 mA in a Beckman model DU spectrophotometer (10) .
The lymphoid cells were collected by centrifugation at 500 X g and resuspended in the RNA preparation for incubation. Incubation time was Zealand animal from which they had come. Evidently (Table I ) autologous spleen cell infusion had no detectable effect on the survival of the control skin homografts.
Adoptive immunity controls. As a basis for comparison with future experimental groups, we attempted to transfer adoptive immunity to skin homografts with lymph node cells obtained from homologous immunized animals. The protocol used in this study is illustrated in Figure 1 . A New Zealand recipient was immunized against a California donor by full thickness skin grafts applied to the lower hind legs and to opposite sides of the chest wall near the axillae. In addition a cell suspension was prepared from the donor spleen and injected into the four foot pads of the recipient. Eight days later, at the time of rejection of the skin homografts, the popliteal and axillary lymph nodes draining the homografts and the sites of spleen cell injection were excised. A cell suspension was prepared from these nodes The survival of these Dutch grafts was in turn not significantly shorter than the survival of Dutch homografts in control animals, p > 0.2.
As a check on the time relationships necessary for effective transfer of adoptive immunity, two further series of experiments were performed in Table V . The average survival of the specific California homografts in these experiments was 5.4 + 1.3 days, a time quite significantly shorter than the survival of first set California homografts in control animals, p < 0.001, and a time very significantly shorter than the survival of the nonspecific Dutch homografts in the same test animals, p < 0.001. Within the dose range employed in these experiments there did not appear to be any correlation between the number of autologous spleen cells administered or the concentration of RNA in the incubation mixture and the results observed. However, on an empirical mal and received simultaneous skin homografts basis 200 x 106 or more spleen cells were infused from the original California donor and from an whenever possible, and we attempted to keep the indifferent Dutch rabbit as before. As shown concentration of RNA in the incubation medium in Table VI the average survival of the specific greater than 100 pg per ml. California homografts in this series of experiEffect of ribonuclease. In this series of ex-ments was 7.0 ± 1.0 days, a time not significantly periments a New Zealand recipient was again different from the survival of first set California immunized against a California donor, and RNA homografts in control animals, p = 1.0, and a time was again extracted from the stimulated lymph also not significantly different from the survival nodes. Incubation with a spleen cell suspension of nonspecific Dutch homografts in the same test from a second New Zealand animal was carried animals, p = 1.0. The addition of RNase to the out as before except that at the time of incuba-RNA preparation at the time of incubation theretion five times recrystallized bovine pancreatic fore apparently prevented the transfer of immunity ribonuclease 2 (RNase), at a concentration of observed in the preceding experiments. Prior 15 ,ug per ml, was added to the incubation me-work from this laboratory had provided assurance dium. After incubation the cells were again col-that RNase at concentrations lower than 50 pg lected, washed, and injected intravenously back * * w ' '~~~~~~~~~per ml would not affect the immunologic capacity into the New Zealand animal from which they had of the lymphoid cells themselves (9, 12 experiments a New Zealand recipient were carried out. In the first series lymph nodes was immunized against a California donor as be-were excised as before from a New Zealand refore. RNA was extracted from the sensitized cipient rabbit immunized against a California lymph nodes and was then injected directly in-donor. RNA was again extracted from these travenously into a second New Zealand animal. lymph nodes and incubated in vitro with a susThis rabbit served as the test animal and received pension of spleen cells from a second New Zeaa specific skin homograft from the original Cali-land animal. After incubation the autologous fornia donor and a nonspecific homograft from spleen cells were infused intravenously back into an indifferent Dutch rabbit. The average sur-the New Zealand animal from which they had vival of the specific California homografts in come. This rabbit served as the test animal and, these experiments was 6.7 + 1.0 days (Table in this case, received a specific skin homograft VII). This time was not significantly different from the original California donor and a nonfrom the survival of first set California homo-specific homograft from an indifferent Dutch grafts in control animals, p > 0.5, and was also rabbit, applied 48 hours after the administration not significantly different from the survival of the of the autologous spleen cells incubated with nonspecific Dutch homografts in the same test ani-RNA. The average survival time of the specific mals, p > 0.6.
California grafts was 7.3 + 0.9 days (Table Autologous spleen cells incubated with immune VIII), a time not significantly different from the RNA 48 hours before and 48 hours after grafting. survival of first set California grafts in control As illustrated in Figure 3 , the California and Dutch homografts excised from five of the six control animals demonstrated only minimal epithelial destruction 4 days after grafting. One unusual control animal had destroyed more than 50%o of the epithelium in both the California and the Dutch grafts 4 days after grafting. In the series of six animals that received RNA-treated autologous spleen cells 48 hours after grafting, the specific California grafts showed from 75 to 100% destruction of the epithelium in four instances (Figure 3) , from 50 to 75%o destruction of the epithelium in one instance, and less than 50% destruction of the epithelium in only one instance. The nonspecific Dutch homografts in these six animals showed only minimal epithelial destruction.
Discussion
The present results appear to indicate that heightened immunity to skin homografts may be transferred by autologous lymphoid cells incubated in vitro with homologous RNA extracted from the lymph nodes of an immunized animal. The mechanism through which this apparent transfer of immunity is accomplished is obviously of considerable importance. The possibility that the transfer is mediated by cell-bound or cellcontained antibody, similar to that recently described by Najarian and Feldman (14) , must be considered. Certainly the RNA preparation used in this laboratory is not free of protein contamination (9) , and it is conceivable that antibodylike material might have been released from the disrupted lymphoid cells during extraction of the RNA, although considerable denaturation of this material would be expected during the multiple phenol extractions used in preparing the RNA. More compelling evidence that contaminating antibody did not play a major role in the transfer of immunity is afforded by the fact that the RNA preparation was ineffective when administered alone, without prior incubation in vitro with autologous lymphoid cells, and by the ability of low concentrations of purified RNase to prevent the transfer of immunity.
Consideration must also be given to the possibility that the heightened immunity observed in our experiments may have been caused by sensitization of the test animal by transplantation antigenic material contaminating the RNA preparation. Nester, Mdkela, and Nossal (15) have presented convincing evidence that antigen may be included with nucleoprotein extracted from lymph nodes engaged in antibody formation. However, that sensitization by contaminating antigen did not produce the heightened immunity observed in the present experiments is indicated by the fact that autologous lymphoid cells incubated with the RNA preparation were ineffective in transferring immunity when administered 48 hours before test skin grafting but were effective when administered at the same time as, or 48 hours after, the application of the test grafts. Certainly, if direct stimulation by contaminating antigen had induced the heightened immune response, administration 48 hours before test grafting should have permitted greater sensitization of the test animals than later injection of the same material. Similarly, although the chemical nature of transplantation antigens in most species is unclear, mouse transplantation antigens (16, 17) and the transplantation antigenic material recently obtained from rabbit cells in this laboratory (18) are insensitive to RNase at concentrations far higher than those which effectively inhibited the transfer of immunity in the present experiments.
Finally the possibility must be considered that the heightened immunity we observed might be a nonspecific result of the exposure of immune competent cells to RNA or its breakdown products during incubation in vitro. That this is not the case, however, is suggested by the specificity of the heightened immune response. The survival of the nonspecific homografts was not detectably affected. Furthermore, nonspecific RNA, extracted from lymph nodes stimulated with BSA and adjuvant, was ineffective in producing accelerated rejection of skin homografts. We have, therefore, tentatively concluded that RNA extracted from sensitized lymph nodes was able to transfer to previously unstimulated lymphoid cells the ability to produce a specific immune response. Metabolic events involved in this transfer are as yet entirely undeciphered; however, it is conceivable that the effects observed may be the result of the addition of a form of "messenger" RNA (19) (20) (21) (22) . However, the fact that a detectable transfer of immunity was observed when immune homologous cells'were used in the present experiments is not surprising, since Warwick, Archer, and Good (23) were able to transfer delayed hypersensitivity to streptokinase in the rabbit with similar numbers of immune, homologous cells, administered intravenously.
Consideration must be given to the effect of 'the time of administration of the cells upon the Billingham, Brent, and Medawar (20) . These investigators found that adoptive immunity to skin homografts could be transferred by immune, isologous lymphoid cells administered 3 days before grafting or at the same time as the test grafts were applied. The isologous cells were much less effective, however, when administered 48 hours after grafting. The reason for the difference between these results and the present findings is unclear; however, it is possible that the period of time during which RNAtreated autologous cells and homologous cells are capable of demonstrating detectable immune competence may be different from that during which immune isologous cells are effective. Moreover species variation may be responsible for differences between the mouse and the rabbit with regard to the time during which newly applied homografts are maximally susceptible to immune attack.
The present experiments are obviously closely allied to the recent work of Fishman and Adler (24) , who have shown that RNA extracted from phage sensitized rat macrophages can, upon incubation with previously unsensitized lymphoid cells, induce in these cells the capacity to form specific antiphage antibody. Also, in parallel with work from this laboratory (9), Fishman, Hammerstrom, and Bond (25) have shown that tritium-labeled RNA extracted from macrophages is incorporated by lymphoid cells during incubation in vitro, and more recently, Fishman (26) has reported that systemic administration of his RNA preparation is ineffective in inducing antibody synthesis in test animals, whereas administration of the RNA in Millipore diffusion chambers is effective, presumably because the RNA in the latter case is taken up by the lymphoid cells that surround the chambers before it can be destroyed by the ribonuclease in the tissue fluids and plasma.
The present RNA preparation also may be closely related to the "transfer factor" of Lawrence and co-workers (27, 28) . Transfer factor as defined by these investigators is a subcellular fraction derived from the circulating blood leukocytes of humans which, upon injection into a homologous individual, has the capacity to transfer various types of delayed hypersensitivity including a heightened immunity to skin homografts. In this respect transfer factor resembles the present RNA preparation, and in addition there is now evidence suggesting that transfer factor is a small polynucleotide possibly associated with polypeptide (29) . Nevertheless, important differences remain, since the present RNA preparation, as opposed to transfer factor, is ineffective when administered alone, without prior incubation with lymphoid cells, and is sensitive to RNase. On the other hand, the small size of the molecule isolated by Lawrence and associates (29) may account for the well-known resistance of their material to RNase. Thus this resistance may be a fortuitous result of species variation and may explain the many failures to reproduce Lawrence's work in experimental animals (27) . The present results and the studies of Fishman noted above would suggest that the capacity to transfer certain types of immunity with an RNA fraction derived from lymphoid cells may be a phenomenon more widespread among mammalian species than was previously supposed. The recent investigations of Fong, Chin, and Vickrey (30) indicate, however, that the transfer of cellular resistance to tubercle bacilli with an RNase sensitive subcellular fraction is much less easily accomplished in the guinea pig than in other mammalian species, notably the rabbit. The guinea pig has previously been the animal most widely used in the experimental study of hypersensitivity.
Finally, the present work has obvious implications for the investigation of tumor immunity. Woodruff and Symes (22) have recently summarized the evidence suggesting that many neo-plasms may be more susceptible to immunological destruction by immune competent cells than by circulating antibody. However, attempts to transfer adoptive or cellular immunity to tumors have been largely confined to experimental situations in which the donor and recipient of the cells were members of the same inbred animal strain (22) . Otherwise the transferred, immune competent cells may be quickly destroyed by the transplantation immune response of the new host and may themselves mount a destructive immunologic attack against the host tissues. The present results suggest a possible solution to these problems through the use of autologous lymphoid cells incubated in vitro with immune homologous or heterologous RNA.
Nevertheless, the establishment of such a system of immune transfer might first require the isolation of tumor specific antigens, obviously a formidable undertaking. Moreover the therapeutic significance of this proposed transfer of cellular immunity to tumors would very likely depend upon the ability of the transferred immune state to become self replicating. Although there is evidence that the transfer factor of Lawrence and co-workers may possess this quality, at least with respect to the transfer of delayed allergy to bacterial antigens (27) , there is no indication from the present study that the immune response produced by RNA-treated autologous cells is anything but short lived. Further investigation of this question will be necessary, however, before a definite conclusion may be drawn. 3. The transfer of immunity by the RNAtreated lymphoid cells was abolished by exposure of the RNA preparation to small amounts of ribonuclease.
4. The RNA preparation was ineffective in transferring immunity when administered directly intravenously without prior incubation in vitro with lymphoid cells.
5. Autologous lymphoid cells, incubated with RNA extracted from lymph nodes stimulated against a protein antigen, were ineffective in inducing the accelerated rejection of skin homografts.
6. RNA-treated, autologous lymphoid cells and immune, homologous lymphoid cells were effective in transferring immunity to skin homografts when infused at the same time as the test grafts were applied or when administered 48 hours after grafting. Neither the homologous cells nor the RNA-treated autologous cells produced a detectable effect when administered 48 hours before the application of the test grafts.
